评估STESS、mRSTESS和EMSE对厄瓜多尔癫痫持续状态患者出院时高残疾和死亡率的预测
该前瞻性研究纳入2015年11月至2018年1月Eugenio Espejo医院的41例癫痫持续状态患者,评估STESS、mRSTESS和EMSE各变体量表对出院时高残疾和医院死亡的预测效能。结果显示,STESS、mRSTESS、EMSE-EAC、EMSE-EACEG和EMSE-ECLEG预测HD/HM的AUC分别为0.71、0.81、0.89、0.90和0.89。二元逻辑回归确定了各量表的截断值对应的OR值。结论认为所有评估量表均有预测价值,EMSE最有效,各变体间相似。
要点
- 在41例癫痫持续状态患者中,出院时高残疾8例(19.5%),死亡13例(31.7%)。
- EMSE-EACEG预测HD/HM的AUC为0.90(95%CI 0.80-1.0),EMSE-ECLEG为0.89(95%CI 0.78-0.99),EMSE-EAC为0.89(95%CI 0.79-0.99)。
- mRSTESS预测HD/HM的AUC为0.81(95%CI 0.67-0.94),STESS为0.71(95%CI 0.55-0.87)。
- 二元逻辑回归显示,STESS的OR为4.80(p=0.02),mRSTESS的OR为7.89(p=0.00),EMSE-EAC的OR为22.16(p=0.00),EMSE-ECLEG的OR为18.00(p=0.00),EMSE-EACEG的OR为14(p=0.00)。
- 结论认为STESS、mRSTESS和EMSE均有助于预测出院时高残疾/死亡,EMSE最有效,各变体间相对相似。
适用人群与场景
- 2015年11月至2018年1月在Eugenio Espejo医院登记的41例癫痫持续状态患者。
研究设计与关键结果
- 前瞻性研究,纳入41例癫痫持续状态患者,评估STESS、mRSTESS和EMSE变体量表对出院时高残疾和医院死亡的预测效能。
- 出院时高残疾8例(19.5%),医院死亡13例(31.7%)。
- 预测HD/HM的AUC:STESS 0.71(95%CI 0.55-0.87),mRSTESS 0.81(95%CI 0.67-0.94),EMSE-EAC 0.89(95%CI 0.79-0.99),EMSE-EACEG 0.90(95%CI 0.80-1.0),EMSE-ECLEG 0.89(95%CI 0.78-0.99)。
- 二元逻辑回归确定截断点对应的OR:STESS OR 4.80(p=0.02),mRSTESS OR 7.89(p=0.00),EMSE-EAC OR 22.16(p=0.00),EMSE-ECLEG OR 18.00(p=0.00),EMSE-EACEG OR 14(p=0.00)。
证据类型、等级与局限
- 证据类型:前瞻性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为STESS、mRSTESS和EMSE均可用于预测癫痫持续状态患者出院时高残疾/死亡,EMSE最有效,各变体间相对相似。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Adequate identification of the severity of status epilepticus (SE) contributes to individualized treatment. The scales most widely used for this purpose are: Status Epilepticus Severity Score (STESS), Epidemiology-Based Mortality Score in Status Epilepticus (EMSE) and modified Rankin Scale STESS (mRSTESS). The aim of this study was to evaluate the performance of the STESS, EMSE and mRSTESS scales to predict high disability and hospital mortality at discharge (HD/HM).
METHODS: A prospective study was conducted in which total of 41 patients were registered from November 2015 to January 2018 at Eugenio Espejo Hospital. Clinical variables such as age, sex, clinical status at the beginning of the SE, initial symptom of SE, as well as the STESS, mRSTESS and EMSE variant scales were studied at the time of the diagnosis of SE.
RESULTS: A total of 41 patients were evaluated, of which 8 (19.5%) had HD at hospital discharge and died 13 (31.7%) during their care. The area under the receiver operating characteristic curve to predict HD/HM was 0.71 (95% CI (confidence interval) 0.55-0.87), 0.81 (95% CI 0.67-0.94), 0.89 (95% CI 0.79-0.99), 0.90 (95% CI 0.80-1.0), 0.89 (95% CI 0.78-0.99) for the STESS, mRSTESS, EMSE-EAC (etiology, age, comorbidities), EMSE-EACEG (etiology, age, comorbidities, electroencephalography) and EMSE-ECLEG (etiology, age, level of consciousness at pre-treatment, electroencephalography), variants of EMSE, respectively. The binary logistic regression demonstrated how the following cut-off points were determined: STESS OR (odd ratio) 4.80 (p = 0.02), mRSTESS OR 7.89 (p = 0.00), EMSE-EAC OR 22.16 (p = 0.00), EMSE-ECLEG OR 18.00 (p = 0.00), EMSE-EACEG OR 14 (p = 0.00).
CONCLUSIONS: All of the evaluated scales (STESS, mRSTESS, and EMSE) were shown to be useful in predicting HD/HM. EMSE was observed to be the most effective of the scales, with relative similarities among the variants.
参考来源
- Rivero Rodríguez D, Scherle Matamoros C, Sam K, et al. Evaluation of STESS, mRSTESS, and EMSE to Predict High Disability and Mortality at Hospital Discharge in Ecuadorian Patients with Status Epilepticus. Neurocrit Care. 2018. PMID: 29949007. doi:10.1007/s12028-018-0549-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。